文献速递头颈部肿瘤放疗

平均血小板体积降低与口咽癌放疗患者不良预后相关

The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy.
PubMed 文献 · Radiat Oncol · 2020-11-07

本研究纳入319例接受放疗的口咽鳞状细胞癌患者,分析平均血小板体积(MPV)与癌症特异性生存(CSS)、局部区域控制(LC)和无复发生存(RFS)的关系。中位MPV为10.30 fL,多因素分析显示MPV是CSS、LC和RFS的独立预后因素,提示其可能有助于个体化风险评估。

要点

  • 中位MPV为10.30 fL,多因素分析显示MPV是CSS的独立预后因素(HR 0.77)。
  • MPV亦是LC(HR 0.80)和RFS(HR 0.83)的独立预后因素。
  • MPV可能作为口咽癌放疗患者的预后标志物,辅助个体化风险评估。

核心结论

  • MPV是接受放疗的口咽鳞状细胞癌患者的预后标志物,可能有助于未来个体化风险评估。

研究设计与样本

  • 回顾性纳入319例在三级学术中心接受放疗的口咽鳞状细胞癌患者,采用Kaplan-Meier法及单因素和多因素Cox比例风险模型分析MPV对CSS、LC和RFS的影响。

主要发现

  • 中位MPV为10.30 fL(均值10.26 ± 1.17 fL)。
  • 单因素分析显示MPV与CSS显著相关(HR 0.85,95%CI 0.74-0.98,p=0.025)。
  • 单因素分析显示MPV与LC显著相关(HR 0.86,95%CI 0.74-0.99,p=0.034)。
  • 单因素分析显示MPV与RFS显著相关(HR 0.87,95%CI 0.76-0.996,p=0.043)。
  • 多因素分析显示MPV是CSS的独立预后因素(HR 0.77,95%CI 0.63-0.93,p=0.008)。

关键数值与推荐

  • 多因素分析中MPV为LC的独立预后因素(HR 0.80,95%CI 0.65-0.98,p=0.030)。
  • 多因素分析中MPV为RFS的独立预后因素(HR 0.83,95%CI 0.685-0.999,p=0.049)。

临床怎么用

  • MPV或可作为口咽癌放疗患者预后评估的参考指标,辅助个体化风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is considerable evidence that platelets contribute to cancer growth and metastatic dissemination. In recent studies, altered mean platelet volume (MPV) has been associated with prognosis in different types of cancer. However, the prognostic role of the MPV in head and neck squamous cell cancer (HNSCC) is currently discussed controversially. The present study was performed to analyze and further elucidate the prognostic significance of the MPV in HNSCC. METHODS: A total of 319 oropharyngeal squamous cell cancer (OPSCC) patients treated with radiotherapy at a tertiary academic center were enrolled in the present study. Kaplan-Meier method as well as uni- and multivariate Cox proportional hazards were used to evaluate the impact of MPV on cancer-specific survival (CSS), locoregional control (LC) and recurrence-free survival (RFS). RESULTS: The median MPV was 10.30 fL (mean 10.26 ± 1.17fL). Univariate analyses showed a significant association of the MPV with CSS (HR 0.85, 95% CI 0.74-0.98, p = 0.025), LC (HR 0.86, 95% CI 0.74-0.99, p = 0.034) and RFS (HR 0.87, 95% CI 0.76-0.996; p = 0.043). In multivariate analysis, the MPV remained an independent prognostic factor for CSS (HR 0.77, 95% CI 0.63-0.93, p = 0.008), LC (HR 0.80, 95% CI 0.65-0.98, p = 0.030), and RFS (HR 0.83, 95% CI 0.685-0.999, p = 0.049). CONCLUSIONS: Our findings indicate that the MPV is a prognostic marker in OPSCC patients and may contribute to future individual risk assessment.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Delago D, Knittelfelder O, Jakse G, et al. The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy. Radiat Oncol. 2020. PMID: 33160368. doi:10.1186/s13014-020-01702-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。